You usually have a number of tests to find out if the symptoms you have could be due to bladder cancer. If you have bladder cancer, you then need more tests to find out how far it has grown. Your GP ...

Researchers have identified 10 genetic mutations that can predict the most common type of bladder cancer up to 12 years prior to diagnosis. The study results were presented at the European Association ...

A faster, cheaper and more reliable test to detect bladder cancer has been developed, US scientists have said. The test, which provides results within an hour, checks for a protein in urine which ...

March 10, 2023: A collaboration between University of Birmingham researchers and liquid biopsy cancer detection and screening company Nonacus, has resulted in a novel test for the non-invasive ...

A new urine test could help detect bladder cancer before symptoms start, according to a recent study. Bladder cancer is the tenth most common cancer worldwide and the fourth most prevalent among men.

You’d think you’d look for signs of bladder cancer in urine, wouldn’t you? Sadly, it’s easier said than done, so there’s normally a need for uncomfortable and invasive cystoscopy exams, with a camera ...

Protect your bladder health with these 5 essential health checks. Learn which tests and screenings you need to maintain ...

Roche and Bavarian Nordic have unveiled plans to assess the former’s anti-PD-L1 antibody Tecentriq in combination with the latter’s cancer vaccine candidate CV301 in bladder cancer. Roche and Bavarian ...

AUSTIN, Texas - Natera, Inc. (NASDAQ:NTRA), a diagnostics company with a market capitalization of $22.37 billion and impressive revenue growth of 44% over the last twelve months, announced Monday that ...

Nearly 20,000 women are diagnosed with bladder cancer each year, according to the American Cancer Society, with most being over age 55. And the unfortunate reality is that women are often diagnosed at ...

Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...